• Doxycycline Beyond Antibiotics: A Translational Strategy

  2026-08-20

  Doxycycline is more than a tetracycline antibiotic: its metalloproteinase inhibition, antimicrobial activity, and antiproliferative effects make it a versatile translational research compound. New targeted delivery work in abdominal aortic aneurysm shows how controlling where and when the compound acts may be as important as the compound itself.

• Spiroplasma Entry into Drosophila S2 Cells

  2026-08-20

  Wei et al. established a Drosophila Schneider 2 cell model showing that Spiroplasma eriocheiris can actively invade insect cells, proliferate intracellularly, and trigger oxidative and cell-death responses. Pharmacological and cytoskeletal experiments identified clathrin-mediated endocytosis and macropinocytosis as major entry routes, providing a tractable framework for studying this crustacean pathogen in an invertebrate cellular system.

• Ridaforolimus: An Assay-First mTOR Strategy

  2026-08-19

  Ridaforolimus (Deforolimus) is examined through an assay-first framework linking mTOR pathway engagement to proliferation, VEGF secretion, apoptosis assay design, and senescence research. The article translates machine-learning senolytic findings into practical decisions for reproducible cancer biology and breast cancer research.

• Biomimetic mRNA Nanovaccines Target Neutrophils in HCC

  2026-08-19

  The reference study presents CMNPs, a cell-membrane-coated mRNA nanovaccine engineered to recognize CD300LD-enriched tumor-associated neutrophils and deliver albumin-fused IL-36γ mRNA. In preclinical hepatocellular carcinoma models, targeted neutrophil activation strengthened antitumor immunity, inhibited tumor growth, and increased survival relative to controls, while also suggesting a practical role for carefully controlled neutrophil preparation in follow-up assays.

• L. gasseri, NR1I3, and E-Cadherin in Colitis

  2026-08-18

  The reference study identifies a mechanistic link between Lactobacillus gasseri ATCC33323 and intestinal barrier protection in DSS-induced colitis. Its central advance is the combination of an intestinal E-cadherin loss-of-function model with transcriptional and in vitro analyses, showing that NR1I3-mediated regulation of CDH1 contributes to the probiotic response.

• YM 58483 (BTP2): From SOCE to Fibrosis Insight

  2026-08-18

  YM 58483 (BTP2) is more than a calcium-entry inhibitor: it is a pathway-level probe for testing how sustained SOCE links immune activation, NFAT signaling, and tissue remodeling. This article connects its established use in T-cell assays with evidence implicating ORAI2-driven SOCE in early postirradiation salivary gland fibrosis, while defining the experimental and translational limits of pharmacologic interpretation.

• 3D Gold Nanocluster Arrays for Reproducible SERS

  2026-08-17

  The reference study introduces polymer pen lithography to fabricate ordered three-dimensional polyethylenimine templates for electrostatic assembly of gold nanoparticle clusters. The resulting substrates combine a reported enhancement factor of 1.67 × 10^7 with an inter-array relative standard deviation below 4.73%, while allowing SERS performance to be adjusted through pattern architecture.

• Tiamulin (Thiamutilin): Research Workflows

  2026-08-17

  Tiamulin (Thiamutilin) connects ribosome-focused antimicrobial testing with cell-based inflammation research. This practical guide covers stock preparation, infection and TNF-α assay design, resistance-aware interpretation, and troubleshooting for veterinary and translational workflows.

• SERT–nNOS Disruption and Fast-Onset Antidepressant Action

  2026-08-16

  The reference study identifies esflurbiprofen as a preclinical fast-onset antidepressant candidate that disrupts the serotonin transporter–neuronal nitric oxide synthase complex in the dorsal raphe nucleus. By combining mBRET-based screening, behavioral models, molecular assays, and resting-state fMRI, the authors connect SERT–nNOS dissociation with altered serotonergic feedback and improved depression-related phenotypes.

• NF 340: A P2Y11 Antagonist for Translational Biology

  2026-08-15

  NF 340 offers a receptor-level way to interrogate purinergic signaling in cancer, immunology, and inflammation research. This article connects P2Y11 blockade with QPRT-driven breast cancer invasiveness, outlines a rigorous validation workflow, and defines the translational limits of current evidence.

• UTP Solution (100 mM) for RNA Assays

  2026-08-14

  Build more consistent transcription, RNA amplification, and siRNA workflows with a prequalified 100 mM nucleotide stock. This practical guide also shows how UTP-supported assay design can help investigate the TRIM66-dependent control of olfactory receptor expression without confusing reagent performance with biological mechanism.

• Tricine-SDS-PAGE Gel Preparation Kit Guide

  2026-08-14

  The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit is designed for resolving low-molecular-weight proteins and peptides, particularly targets in the 1–10 kDa range. It supports research workflows involving denaturing or non-denaturing electrophoresis, but it is not intended for diagnostic, clinical, or medical use.

• SGI-1027: DNA Methyltransferase Inhibition

  2026-08-13

  SGI-1027 is a non-nucleoside DNA methyltransferase inhibitor for connecting DNMT blockade with promoter demethylation, tumor suppressor gene reactivation, and apoptosis readouts. This workflow-focused guide covers assay design, handling, comparative advantages, and troubleshooting for cancer epigenetics research.

• 3-Deazaneplanocin (DZNep) Workflow Guide

  2026-08-13

  Build reproducible DZNep experiments around SAHH inhibition, EZH2 depletion, apoptosis, and tumor-initiating cell assays. This guide connects AML, hepatocellular carcinoma, and breast cancer workflow design while emphasizing dose selection, phenotype-specific controls, and troubleshooting.

• Concanamycin A: A Trafficking-Centered Assay Guide

  2026-08-12

  Concanamycin A is a V-type H+-ATPase inhibitor that reveals how organelle acidification shapes autophagy, trafficking, apoptosis, and tumor-cell invasion. This guide connects the compound’s acute pharmacology with a recent ER-exit-site study to improve mechanistic assay design.

15416 records 1/1028 page Next 12345 下5页 Last page